DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2BANZEL
02 2DIVALPROEX SODIUM
03 1EXTENDED PHENYTOIN SODIUM
04 1GLIPIZIDE
05 1MELOXICAM
06 1METAPROTERENOL SULFATE
07 1MORPHINE SULFATE
08 1NIFEDIPINE
09 1PENTOXIFYLLINE
10 1PHENYTEK
01 121530
02 121911
03 240298
04 173632
05 175028
06 175289
07 176467
08 190070
09 190161
10 1201367
11 1205634
01 12No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90070
Country : US
Patented : No
Drug : GLIPIZIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76467
Country : US
Patented : No
Drug : NIFEDIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75289
Country : US
Patented : No
Drug : PENTOXIFYLLINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75028
Country : US
Patented : No
Drug : METAPROTERENOL SULFATE
Dosage Form : SYRUP; ORAL
Application Number : 73632
Country : US
Patented : No
Drug : BANZEL
Dosage Form : SUSPENSION; ORAL
Application Number : 201367
Country : US
Patented : No
Drug : BANZEL
Dosage Form : TABLET; ORAL
Application Number : 21911
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 205634
Country : US
Patented : No
Drug : EXTENDED PHENYTOIN SODIUM
Dosage Form : CAPSULE; ORAL
Application Number : 40298
Country : US
Patented : No
Drug : PHENYTEK
Dosage Form : CAPSULE; ORAL
Application Number : 40298
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
